Product
CU-40101
1 clinical trial
1 indication
Indication
AGAClinical trial
A Phase I Clinical Trial Evaluating the Safety, Tolerability, and Pharmacokinetics of CU-40101 Liniment in Single and Multiple Doses in Adult Male Androgenic Alopecia SubjectsStatus: Recruiting, Estimated PCD: 2023-11-01